William R. Kem

Prof. William R. Kem


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2004 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
WKWilliam R. Kem
William R. Kem
VMVladimir M. Mahnir
Vladimir M. Mahnir
Laszlo ProkaiLaszlo Prokai
Laszlo Prokai
RPRoger L. Papke
Roger L. Papke
XCXuefang Cao
Xuefang Cao
FSFerenc Soti
Ferenc Soti
3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride (DMXBA; GTS-21), an Alzheimer9s drug candidate, selectively stimulates α7 nicotinic acetylcholine receptors. It rapidly enters the brain after oral administration and enhances cognitive behavior. Less than 1% of orally administered DMXBA is recovered in the urine. We report the identification and characterization of the major phase I metabolites of this drug candidate. Three hydroxy metabolites were generated in vitro by hepatic microsomal O-dealkylation of the two methoxy substituents on the benzylidene ring. They were also found in plasma of rats after oral administration, but at significantly lower concentrations relative to the parent compound. The metabolites displayed similar binding affinities and partial agonist potencies at rat brain α7 receptors. However, each displayed a higher efficacy than DMXBA for stimulating rat and human α7 receptors. Like DMXBA, the metabolites were weak antagonists at α4β2 receptors. The predicted conformations of the metabolites were nearly identical with that of DMXBA. Ionization of the tetrahydropyridyl nitrogen was essential for high-affinity binding of DMXBA to the α7 receptor. The hydroxy metabolites were much more polar than DMXBA, derived from their experimentally estimated octanol/water partition coefficients, and they entered the brain much less readily than DMXBA. Their contributions to the behavioral effects of orally administered DMXBA, if any, would probably be very small during short-term administration. Benzylidene anabaseines pharmacologically similar to the hydroxy metabolites, but which enter the brain more readily, may provide greater stimulation of α7 receptors in the whole organism.

6 April 2006 in Marine Drugs
Verified
Journal Article
Open access
PDF file
WKWilliam R. Kem
William R. Kem
FSFerenc Soti
Ferenc Soti
KWKristin Wildeboer
Kristin Wildeboer
SLSusan LeFrancois
Susan LeFrancois
KMKelly MacDougall
Kelly MacDougall
HAHugo R. Arias
Hugo R. Arias
Nemertines are a phylum of carnivorous marine worms that possess a variety of alkaloidal, peptidic or proteinaceous toxins that serve as chemical defenses against potential predators. The hoplonemertines additionally envenomate their prey with a mixture of proboscis alkaloids delivered with the help of a calcareous stylet that punctures the skin of the victim. Anabaseine, the first of these alkaloids to be identified, stimulates a wide variety of animal nicotinic acetylcholine receptors (AChRs), especially the neuromuscular [e.g., α12β1γδ (embryogenic) or α12β1γε (adult)] and α7 AChRs that are inhibited by the snake peptide α-bungarotoxin. A synthetic derivative, 3-(2,4-Dimethoxybenzylidene)-Anabaseine (DMXBA; also called GTS-21), improves memory in experimental animals and humans and is currently in clinical trials to determine whether it can ameliorate cognitive problems associated with schizophrenia. Here we summarize present knowledge concerning the chemistry and mechanisms of action of these two substances (anabaseine and DMXBA) on AChRs, especially those found in the mammalian brain.


1 July 2003 in Biomolecular Engineering
Verified
Journal Article
Closed access
WKWilliam R. Kem
William R. Kem
FSFerenc Soti
Ferenc Soti
DRDan Rittschof
Dan Rittschof

1 August 2004 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
WKWilliam R. Kem
William R. Kem
KWKristin Wildeboer
Kristin Wildeboer
SLSusan LeFrancois
Susan LeFrancois
MRMa'AN Raja
Ma'AN Raja
WMWilliam Marszalec
William Marszalec
JBJean-Claude Braekman
Jean-Claude Braekman